#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Necrotising enterocolitis neonatal Neuropathy peripheral Dupuytren's contracture Lymphoma Warm autoimmune haemolytic anaemia Castleman's disease Niemann-Pick disease Acute leukaemia Thrombotic microangiopathy Stress cardiomyopathy B-cell type acute leukaemia Barth syndrome Juvenile idiopathic arthritis Drug eruption Polyneuropathy More trials…

    Learn about Rare Diseases

    Choroid melanoma – Trials in Disease Adrenocortical carcinoma Hepatoblastoma Synovial sarcoma recurrent – Treatment Myelodysplastic syndrome with excess blasts – Diagnostics Gastrointestinal stromal tumour – Basic Information Rhabdomyosarcoma recurrent – Trials in Disease Alagille syndrome – Life with Disease Wiskott-Aldrich syndrome – Diagnostics Glycogen storage disease type I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenobarbital Gsk4381562A FIBRIN Ciclesonide Barzolvolimab Cabazitaxel Elebsiran Vibosameran Casimersen Tryptophan Desoximetasone Trastuzumab Deruxtecan Allo-501A Alogliptin Memantine Hydrochloride Quinapril Hydrochloride Talquetamab Gemcitabine Golimumab Lovo-B More therapies…

    Learn about Your Condition

    Retinoblastoma Toxic nodular goitre Dent's disease Tuberous sclerosis complex Diarrhoea Lung disorder Acute promyelocytic leukaemia Juvenile psoriatic arthritis Deafness Chronic sinusitis Breast cancer stage IV Metastases to liver Small intestine leiomyosarcoma Eyelid ptosis Transplantation complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Glucose Monohydrate Ph. Eur.
    • Levocarnitine
    • Magnesium Chloride Hexahydrate
    Denmark Germany Italy Spain Sweden

  • Testosterone Treatment for Boys with Klinefelter Syndrome: A Study on Body Composition Changes During Puberty

    Recruiting

    3 1
    Investigated Diseases:
    • Klinefelter’s syndrome
    Investigated Drugs:
    • Testosterone
    Denmark

  • Study on Radiotherapy and Antiandrogens for Patients with Advanced Prostate Cancer Using Abiraterone Acetate and Enzalutamide

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Enzalutamide
    Spain

  • Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Bupivacaine Hydrochloride, Anhydrous
    • Extract Of Fresh Opium Poppy (1:2.2-2.7), Extraction Solvent: Ethanol 31.2 % (M/M)
    Sweden

  • Study on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)

    Recruiting

    4 1 1
    Investigated Drugs:
    • Sibeprenlimab
    Belgium Croatia Czechia France Germany Greece +6

  • Study on the Effects of Acetylsalicylic Acid and Atorvastatin in Patients with Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Atorvastatin
    Czechia France
Previous Page
1 … 7 8 9 10 11 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!